Article
Current and evolving understanding of atypical chronic myeloid leukemia.
Blood reviews - 1 Jan 2019
Schwartz Lauren C, Mascarenhas John
Abstract excerpt
Atypical chronic myeloid leukemia (aCML) is a BCR-ABL1 negative myelodysplastic (MDS)/myeloproliferative (MPN) neoplasm with poor overall survival. The current 2016 WHO classification of myeloid neoplasms allows clinicians to more accurately differentiate aCML from its similar MDS/MPN overlap and MPN counterparts. In addition, the advent of next-generation sequencing has expanded our understanding of the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
